Howard Ozer

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

Jeffrey Crawford, Howard Ozer, Ronald G. Stoller et al. · New England Journal of Medicine · 1991 · 1.4K citations

Life Sciences, Immunology, Oncology +16

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Howard Ozer, Jamés O. Armitage, Charles L. Bennett et al. · Journal of Clinical Oncology · 2000 · 1K citations

Medicine, Hematology, Oncology +8

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer

Michael Fanucchi, John A. Glaspy, Jeffrey Crawford et al. · New England Journal of Medicine · 1997 · 294 citations · Full text

Medicine, Oncology, Pharmacology +8